For researchers and procurement specialists in the pharmaceutical industry, understanding the price and availability of critical raw materials is fundamental to project planning and budget management. (S)-1-Boc-3-hydroxypiperidine (CAS 143900-44-1) is one such compound, highly sought after for its role as a chiral intermediate in the synthesis of various APIs, most notably Ibrutinib. Accessing a consistent and cost-effective supply is crucial for drug development pipelines.

The price of (S)-1-Boc-3-hydroxypiperidine can fluctuate based on several factors, including purity levels, order volume, and the supplier's manufacturing capabilities. High-purity grades, essential for pharmaceutical applications, typically command a higher price. When searching for '(S)-1-Boc-3-hydroxypiperidine price,' buyers often find that sourcing directly from manufacturers in China offers competitive pricing structures, especially for bulk orders. It is advisable to request detailed quotes from multiple reputable suppliers to compare pricing and terms.

Availability is equally important. Manufacturers employing efficient synthesis routes, such as biotransformation or optimized chemical resolutions, can ensure a more stable and scalable supply. Buyers should inquire about the lead times for different quantities and the manufacturer's production capacity. For critical projects, securing a long-term supply agreement can mitigate risks associated with market volatility. Searching for 'pharmaceutical intermediate supplier' and then filtering by product and region (e.g., China) can help identify reliable vendors.

When evaluating potential suppliers, beyond price, consider their track record in the industry, their quality control processes, and their ability to provide necessary documentation such as Certificates of Analysis (CoA). For companies actively looking to purchase this compound, engaging with manufacturers that specialize in chiral intermediates and have a demonstrated history of reliable delivery is the most prudent approach to ensuring both quality and consistent availability of (S)-1-Boc-3-hydroxypiperidine for their ongoing research and production needs.